Merck & Co.

By person

16 insiders · 0 transactions

36.9×

Robert M. Davis holds 36.9 times base salary in stock. $60.80M of shares against $1.65M in salary for 2025.

Salary from the company's own proxy. The shares are what Robert M. Davis last reported holding, valued at $135.00, the price Common Stock was last bought or sold at on the open market here, on 13 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Davis Robert M

Chairman, CEO & President

—

450,351

$60.80M

+29.3%

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

—

110,167

$14.87M

−31.3%

Li Dean Y

Executive VP & President, MRL

—

94,431

$12.75M

+92.0%

Litchfield Caroline

EVP & CFO

—

92,301

$12.46M

+80.9%

Zachary Jennifer

EVP, General Counsel

—

45,509

$6.14M

+40.5%

Guindo Chirfi

EVP, Access, Policy & Comms

—

36,613

$4.94M

−16.5%

Williams David Michael

EVP,Chief Info&Digital Officer

—

31,716

$4.28M

+54.1%

Romanelli Joseph

President, Human Health Int?l

—

28,739

$3.88M

+37.9%

Oosthuizen Johannes Jacobus

EVP, Oncology & Int?l

—

21,895

$2.96M

−10.3%

Maraldo David R.

EVP & Pres. MMD

—

18,212

$2.46M

+2.2%

BAKER DOUGLAS M JR

Director

—

16,000

$2.16M

+1,500%

Chattopadhyay Sanat

Exe V-P & Pres. MMD

—

15,347

$2.07M

—

Larson Betty D

EVP, Chief HR Officer

—

13,774

$1.86M

—

Smart Dalton E. III

SVP Fin. - Global Controller

—

9,388

$1.27M

+110.4%

THULIN INGE G

Director

—

2,933

$395.94K

+2,833%

Downing Cristal N

Chief Comm. & Public Afrs Ofcr

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

By person

Individual transactions

What was left out